Plasma von Willebrand factor antigen levels in non-small cell lung cancer patients

Anticancer Res. 2005 Jan-Feb;25(1B):403-7.

Abstract

Background: To analyze the behavior of circulating von Willebrand factor antigen (vWf:Ag) in patients with non-small cell lung cancer (NSCLC).

Patients and methods: Pre-surgical vWf:Ag levels were measured in 64 patients with histologically diagnosed NSCLC compared to 64 patients with benign pulmonary diseases, as well as 64 age- and sex-matched controls.

Results: Patients with NSCLC had mean vWf:Ag concentrations lower than either controls or benign patients (p =0.001). CEA was the only variable predictive of low vWf:Ag levels (p<0.01). Five of the 64 NSCLC patients had abnormally low vWf:Ag concentrations (<36 IU/dL). When these patients were excluded from the analysis, the vWf:Ag levels of NSCLC patients did not differ from those of controls (p=0.19).

Conclusion: The vWf antigen levels of NSCLC patients are not substantially altered. A small subset of these patients will have a depletion of circulating vWf:Ag, probably because of a paraneoplastic process associated with an advanced stage of disease.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Age Factors
  • Aged
  • Aged, 80 and over
  • Carcinoembryonic Antigen / biosynthesis
  • Carcinoma, Non-Small-Cell Lung / blood*
  • Female
  • Humans
  • Immunoassay
  • Lung Neoplasms / blood*
  • Male
  • Middle Aged
  • Regression Analysis
  • Sex Factors
  • Time Factors
  • von Willebrand Factor / biosynthesis*

Substances

  • Carcinoembryonic Antigen
  • von Willebrand Factor